Eléments de l'association

	B. I. Rini	1
	Protein Kinase Inhibitors (therapeutic use)	15
	B. I. Rini *Sauf* Protein Kinase Inhibitors (therapeutic use)"	0
	Protein Kinase Inhibitors (therapeutic use) *Sauf* B. I. Rini"	14
	B. I. Rini Et Protein Kinase Inhibitors (therapeutic use)	1
	B. I. Rini Ou Protein Kinase Inhibitors (therapeutic use)	15
	*Corpus*	4588

List of bibliographic references

Number of relevant bibliographic references: 1.

Ident.	Authors (with country if any)	Title
001241	B. Escudier [France] ; M. D. Michaelson [États-Unis] ; R. J. Motzer [États-Unis] ; T. E. Hutson [États-Unis] ; J. I. Clark [États-Unis] ; H. Y. Lim [Corée du Sud] ; E. Porfiri [Royaume-Uni] ; P. Zalewski [Canada] ; G. Kannourakis [Australie] ; M. Staehler [Allemagne] ; J. Tarazi [États-Unis] ; B. Rosbrook [États-Unis] ; L. Cisar [États-Unis] ; S. Hariharan [États-Unis] ; S. Kim [États-Unis] ; B. I. Rini [États-Unis]	Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024